22NW Fund portfolio — 13F holdings Q3 2026
22NW Fund (Aron English) reported 12 long positions worth $107.2 million as of 2026-09-30. Top holdings: INSPERITY, INC., NEKTAR THERAPEUTICS, Turtle Beach Corp, STONERIDGE INC, CORE MOLDING TECHNOLOGIES INC. Quarterly changes and source links to the original SEC 13F filings. Long options are listed separately in the interactive view.
Reported share positions (up to 20)
| Company | Report period | Value | Portfolio weight | Change | Source |
|---|---|---|---|---|---|
| INSPERITY, INC. | 2026-09-30 | 22968870.00 USD | 15.92% | hold | Original filing |
| NEKTAR THERAPEUTICS | 2026-09-30 | 17020108.00 USD | 11.79% | hold | Original filing |
| Turtle Beach Corp | 2026-09-30 | 16663292.00 USD | 11.55% | add | Original filing |
| STONERIDGE INC | 2026-09-30 | 16405384.00 USD | 11.37% | hold | Original filing |
| CORE MOLDING TECHNOLOGIES INC | 2026-09-30 | 7855370.00 USD | 5.44% | add | Original filing |
| CULP INC | 2026-09-30 | 6897116.00 USD | 4.78% | hold | Original filing |
| Walker & Dunlop, Inc. | 2026-09-30 | 6041413.00 USD | 4.19% | buy | Original filing |
| UNIFI INC | 2026-09-30 | 5550206.00 USD | 3.85% | reduce | Original filing |
| TEAM INC | 2026-09-30 | 4880963.00 USD | 3.38% | hold | Original filing |
| Eledon Pharmaceuticals, Inc. | 2026-09-30 | 1610001.00 USD | 1.12% | hold | Original filing |
| Blend Labs, Inc. | 2026-09-30 | 1277071.00 USD | 0.88% | buy | Original filing |
| LIFECORE BIOMEDICAL, INC. \DE\ | 2026-09-30 | 8251.00 USD | 0.01% | hold | Original filing |
| Mineralys Therapeutics, Inc. | 2026-06-30 | — | — | exited | Original filing |
| REGENXBIO Inc. | 2026-06-30 | — | — | exited | Original filing |
| Rezolute, Inc. | 2026-06-30 | — | — | exited | Original filing |
Recent source filings (up to 20)
| Report period | Filed | Form | Source |
|---|---|---|---|
| 2026-09-30 | 2026-11-13 00:00:00 | 13F-HR | Original filing |
| 2026-06-30 | 2026-08-14 00:00:00 | 13F-HR | Original filing |
| 2026-03-31 | 2026-05-15 00:00:00 | 13F-HR | Original filing |
| 2025-12-31 | 2026-02-13 00:00:00 | 13F-HR | Original filing |
| 2025-09-30 | 2025-11-14 00:00:00 | 13F-HR | Original filing |
| 2025-06-30 | 2025-08-14 00:00:00 | 13F-HR | Original filing |
| 2025-03-31 | 2025-05-14 00:00:00 | 13F-HR | Original filing |
| 2024-12-31 | 2025-02-14 00:00:00 | 13F-HR | Original filing |
| 2024-09-30 | 2024-11-14 00:00:00 | 13F-HR | Original filing |
| 2024-06-30 | 2024-08-14 00:00:00 | 13F-HR | Original filing |
| 2024-03-31 | 2024-05-15 00:00:00 | 13F-HR | Original filing |
| 2023-12-31 | 2024-02-14 00:00:00 | 13F-HR | Original filing |
| 2023-09-30 | 2023-11-14 00:00:00 | 13F-HR | Original filing |
| 2023-06-30 | 2023-08-14 00:00:00 | 13F-HR | Original filing |
| 2023-03-31 | 2023-05-15 00:00:00 | 13F-HR | Original filing |
| 2022-12-31 | 2023-02-10 00:00:00 | 13F-HR | Original filing |
| 2022-09-30 | 2022-11-14 00:00:00 | 13F-HR | Original filing |
| 2022-06-30 | 2022-08-12 00:00:00 | 13F-HR | Original filing |
| 2022-03-31 | 2022-05-13 00:00:00 | 13F-HR | Original filing |
| 2021-12-31 | 2022-02-14 00:00:00 | 13F-HR | Original filing |
Public disclosures can be delayed, incomplete, or amended. Report period describes a position date; transaction date describes a reported transaction; filed describes submission. A recent filing or page update does not establish a current holding. A dash means unavailable or not comparable, not zero.
This public summary shows the default reporting scope. Enable JavaScript for interactive filters, charts, and additional rows.